{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:56:18Z","timestamp":1793422578188,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005205","name":"Janssen Research and Development LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012416","name":"Inova Diagnostics Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012416","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Microdrop LLC"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["UM1 AI110498"],"award-info":[{"award-number":["UM1 AI110498"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["AI110503"],"award-info":[{"award-number":["AI110503"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["UM1AI110503"],"award-info":[{"award-number":["UM1AI110503"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.clinthera.2019.04.028","type":"journal-article","created":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T23:59:28Z","timestamp":1560124768000},"page":"1256-1269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["The Natural History of Rheumatoid Arthritis"],"prefix":"10.1016","volume":"41","author":[{"given":"Kevin D.","family":"Deane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Michael","family":"Holers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2019.04.028_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib2","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib3","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/annrheumdis-2011-200990","article-title":"EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis","volume":"71","author":"Gerlag","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/annrheumdis-2017-212763","article-title":"Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study","volume":"78","author":"Gerlag","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib5","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/art.40061","article-title":"Editorial: prevention of rheumatoid arthritis: now is the time, but how to proceed?","volume":"69","author":"Deane","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.028_bib6","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.clinthera.2019.04.012","article-title":"Mucosal biology and the development of rheumatoid arthritis: potential for prevention by targeting mucosal processes","volume":"41","author":"Demoruelle","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2019.04.028_bib7","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.clinthera.2019.04.017","article-title":"Predicting Rheumatoid Arthritis in At-Risk Individuals","volume":"41","author":"van Boheemen","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2019.04.028_bib8","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.clinthera.2019.04.013","article-title":"Nomenclature for the stages of development of rheumatoid arthritis","volume":"41","author":"Raza","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2019.04.028_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrrheum.2016.52","article-title":"Family history of rheumatoid arthritis: an old concept with new developments","volume":"12","author":"Frisell","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.028_bib10","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/art.1780311004","article-title":"The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study","volume":"31","author":"del Puente","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.56.6.351","article-title":"Serum immunoglobulins and the risk of rheumatoid arthritis","volume":"56","author":"Aho","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib12","first-page":"1282","article-title":"Rheumatoid factors antedating clinical rheumatoid arthritis","volume":"18","author":"Aho","year":"1991","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.028_bib13","first-page":"2743","article-title":"Antifilaggrin antibodies within \"normal\" range predict rheumatoid arthritis in a linear fashion","volume":"27","author":"Aho","year":"2000","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.028_bib14","first-page":"1278","article-title":"Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process","volume":"20","author":"Aho","year":"1993","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.028_bib15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/rheumatology\/31.6.365","article-title":"Incidence of rheumatoid arthritis in a genetically predisposed population","volume":"31","author":"Silman","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.028_bib16","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib17","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/ard.2007.076679","article-title":"Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis","volume":"67","author":"Majka","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib19","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3899\/jrheum.080895","article-title":"Comparison of threshold cutpoints and continuous measures of anti-cyclic citrullinated peptide antibodies in predicting future rheumatoid arthritis","volume":"36","author":"Chibnik","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.028_bib20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/ard.2008.105759","article-title":"Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study","volume":"69","author":"Bos","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.clinthera.2019.04.028_bib21","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/annrheumdis-2012-202127","article-title":"A\u00a0prediction rule for the development of arthritis in seropositive arthralgia patients","volume":"72","author":"van de Stadt","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib22","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1136\/annrheumdis-2012-202254","article-title":"Smoking and overweight determine the likelihood of developing rheumatoid arthritis","volume":"72","author":"de Hair","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib23","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/art.39297","article-title":"Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the disease","volume":"67","author":"Ramos-Remus","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.028_bib24","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1136\/annrheumdis-2014-205227","article-title":"Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study","volume":"74","author":"Rakieh","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib25","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1093\/rheumatology\/kex360","article-title":"The association between omega-3 fatty acid biomarkers and inflammatory arthritis in an anti-citrullinated protein antibody positive population","volume":"56","author":"Gan","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2019.04.028_bib26","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.27570","article-title":"Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis","volume":"62","author":"Kolfenbach","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/annrheumdis-2013-204154","article-title":"Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis","volume":"73","author":"Shi","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib28","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3899\/jrheum.140767","article-title":"Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis","volume":"42","author":"Gan","year":"2015","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.028_bib29","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1002\/art.22279","article-title":"Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response","volume":"54","author":"Verpoort","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib30","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1002\/art.23127","article-title":"Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles","volume":"56","author":"Verpoort","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/2e462817-ab93-4d78-95a4-1d8b9d172971","article-title":"Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis","volume":"7","author":"Sokolove","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2019.04.028_bib32","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1002\/art.27638","article-title":"The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner","volume":"62","author":"Deane","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clim.2018.05.004","article-title":"Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritis","volume":"195","author":"Lingampalli","year":"2018","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clinthera.2019.04.028_bib34","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/art.40562","article-title":"Triple positivity for anti-citrullinated protein autoantibodies, rheumatoid factor, and anti-carbamylated protein antibodies conferring high specificity for rheumatoid arthritis: implications for very early identification of at-risk individuals","volume":"70","author":"Verheul","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.028_bib35","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/art.38307","article-title":"Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis","volume":"66","author":"Sokolove","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.028_bib36","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/art.33489","article-title":"Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritis","volume":"64","author":"Suwannalai","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib37","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/art.27533","article-title":"Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis","volume":"62","author":"Ercan","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib38","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/annrheumdis-2013-203565","article-title":"Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis","volume":"74","author":"Rombouts","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/ard.2005.040659","article-title":"Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis","volume":"65","author":"Nielen","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/art.27186","article-title":"Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis","volume":"62","author":"Kokkonen","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib41","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1002\/art.20431","article-title":"Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib42","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.clinthera.2019.04.028_bib43","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/annrheumdis-2012-202753","article-title":"The type I IFN signature as a biomarker of preclinical rheumatoid arthritis","volume":"72","author":"Lubbers","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib44","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1136\/annrheumdis-2015-207324","article-title":"B\u00a0cell signature contributes to the prediction of RA development in patients with arthralgia","volume":"74","author":"Lubbers","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib45","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/art.34449","article-title":"Familial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients","volume":"64","author":"El-Gabalawy","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fmed.2018.00219","article-title":"Survivin measurement improves clinical prediction of transition from arthralgia to RA-biomarkers to improve clinical sensitivity of transition from arthralgia to RA","volume":"5","author":"Erlandsson","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clinthera.2019.04.028_bib47","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13075-016-0975-4","article-title":"A\u00a0prospective cohort study of 14-3-3eta in ACPA and\/or RF-positive patients with arthralgia","volume":"18","author":"van Beers-Tas","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinthera.2019.04.028_bib48","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13075-016-1102-2","article-title":"Changes in peripheral blood lymphocyte subsets during arthritis development in arthralgia patients","volume":"18","author":"Lubbers","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinthera.2019.04.028_bib49","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1136\/annrheumdis-2015-207991","article-title":"T\u00a0cell subsets: an immunological biomarker to predict progression to clinical arthritis in ACPA-positive individuals","volume":"75","author":"Hunt","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib50","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1136\/annrheumdis-2017-211351","article-title":"Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis","volume":"76","author":"Tak","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib51","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90045","article-title":"A\u00a0molecular signature of preclinical rheumatoid arthritis triggered by dysregulated PTPN22","volume":"1","author":"Chang","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.clinthera.2019.04.028_bib52","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1002\/art.39771","article-title":"Elevated IgA plasmablast levels in subjects at risk of developing rheumatoid arthritis","volume":"68","author":"Kinslow","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.028_bib53","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.25036","article-title":"Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients","volume":"62","author":"Snir","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib54","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/annrheumdis-2012-202127","article-title":"A\u00a0prediction rule for the development of arthritis in seropositive arthralgia patients","volume":"72","author":"van de Stadt","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib55","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.34344","article-title":"Brief Report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity?","volume":"64","author":"Demoruelle","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13075-018-1767-9","article-title":"The value of joint ultrasonography in predicting arthritis in seropositive patients with arthralgia: a prospective cohort study","volume":"20","author":"van Beers-Tas","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinthera.2019.04.028_bib57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/art.30655","article-title":"Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: findings of a prospective pilot study","volume":"64","author":"Gent","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib58","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.38273","article-title":"Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis","volume":"66","author":"de Hair","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.028_bib59","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41584-018-0070-0","article-title":"Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction","volume":"14","author":"Holers","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"10.1016\/j.clinthera.2019.04.028_bib60","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38066","article-title":"Sputa autoantibodies in patients with established rheumatoid arthritis and subjects at-risk for future clinically apparent disease","volume":"65","author":"Willis","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib61","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01202","article-title":"Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis","volume":"2","author":"Scher","year":"2013","journal-title":"eLife"},{"key":"10.1016\/j.clinthera.2019.04.028_bib62","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/art.34539","article-title":"Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis","volume":"64","author":"Scher","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2017.08.003","article-title":"Genetic and environmental risk factors for rheumatoid arthritis","volume":"31","author":"Deane","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.028_bib64","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.clinthera.2019.04.021","article-title":"Potential of lifestyle changes for reducing the risk of developing rheumatoid arthritis: is an ounce of prevention worth a pound of cure?","volume":"41","author":"Zaccardelli","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2019.04.028_bib65","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","article-title":"The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis","volume":"30","author":"Gregersen","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib66","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.2006.060004","article-title":"Rheumatoid factor seropositivity is inversely associated with oral contraceptive use in women without rheumatoid arthritis","volume":"66","author":"Bhatia","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib67","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.rdc.2012.04.002","article-title":"Environmental and gene-environment interactions and risk of rheumatoid arthritis","volume":"38","author":"Karlson","year":"2012","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clinthera.2019.04.028_bib68","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/annrheumdis-2016-209154","article-title":"Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritis","volume":"76","author":"Gan","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib69","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/annrheumdis-2014-205522","article-title":"Characterising arthralgia in the preclinical phase of rheumatoid arthritis using MRI","volume":"74","author":"van Steenbergen","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib70","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/annrheumdis-2015-208094","article-title":"Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism","volume":"75","author":"Wigerblad","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrrheum.2016.200","article-title":"Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis","volume":"13","author":"Catrina","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.028_bib72","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/annrheumdis-2016-209846","article-title":"EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis","volume":"76","author":"van Steenbergen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib73","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1093\/rheumatology\/kex324","article-title":"Validation of the EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis","volume":"56","author":"Burgers","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2019.04.028_bib74","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3899\/jrheum.120736","article-title":"Anticitrullinated protein antibodies and rheumatoid factor fluctuate in early inflammatory arthritis and do not predict clinical outcomes","volume":"40","author":"Barra","year":"2013","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.028_bib75","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/rheumatology\/keq190","article-title":"Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: a systematic literature review","volume":"50","author":"Barra","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2019.04.028_bib76","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s11926-012-0275-1","article-title":"Treatment strategies in early rheumatoid arthritis and prevention of rheumatoid arthritis","volume":"14","author":"Demoruelle","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.clinthera.2019.04.028_bib77","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1136\/annrheumdis-2012-201893","article-title":"Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials","volume":"71","author":"Raza","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.028_bib78","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/acr.23474","article-title":"Treating early undifferentiated arthritis: a systematic review and meta-analysis of direct and indirect trial evidence","volume":"70","author":"Lopez-Olivo","year":"2018","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"10.1016\/j.clinthera.2019.04.028_bib79","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.clinthera.2019.04.018","article-title":"Extra-articular manifestations and comorbidity in rheumatoid arthritis: potential impact of pre-rheumatoid arthritis prevention","volume":"41","author":"Giles","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2019.04.028_bib80","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib81","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.rmed.2012.03.006","article-title":"Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease","volume":"106","author":"Fischer","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.clinthera.2019.04.028_bib82","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/ibd\/izy235","article-title":"Increased burden of psychiatric disorders in inflammatory bowel disease","volume":"25","author":"Bernstein","year":"2019","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.clinthera.2019.04.028_bib83","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1002\/art.38017","article-title":"Performance of anti-cyclic citrullinated Peptide assays differs in subjects at increased risk of rheumatoid arthritis and subjects with established disease","volume":"65","author":"Demoruelle","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.028_bib84","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3899\/jrheum.170446","article-title":"Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis","volume":"45","author":"Lac","year":"2018","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.028_bib85","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13075-015-0665-7","article-title":"Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis","volume":"17","author":"Habets","year":"2015","journal-title":"Arthritis Res Ther"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819301924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819301924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:50:53Z","timestamp":1758963053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291819301924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":85,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0149291819301924"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.04.028","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Natural History of Rheumatoid Arthritis","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.04.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}